Clinical Trial Update: Effect of Treatment With Insulin Sensitizer on Arterial Properties, Metabolic Parameters and Liver Function in Patients With Nonalcoholic Fatty Liver Disease [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update summarizes Phase 1/2 results for an insulin sensitizer used to evaluate effects on arterial properties, metabolic parameters, and liv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Fatty Liver Disease

Snippet

Sponsor: Wolfson Medical Center | Conditions: Nonalcoholic Fatty Liver Disease | Phase 1, Phase 2 | Status: COMPLETED